SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001042167-23-000059
Filing Date
2023-09-19
Accepted
2023-09-19 11:56:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G cyto_13g.txt SC 13G 4324
  Complete submission text file 0001042167-23-000059.txt   6010
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-32837 | Film No.: 231262956
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 353 NASSAU ST PRINCETON NJ 08540 6096835883
CYTOVANCE BIOLOGICS INC (Filed by) CIK: 0001231100 (see all company filings)

IRS No.: 000000000
Type: SC 13G